Baxter; John D.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Baxter; John D..The latest application filed is for "nuclear receptor ligands and ligand binding domains".
- Baxter; John D. - West Melbourne FL
- Baxter; John D. - San Francisco CA
| Patent | Date |
|---|---|
| Cylindrical container bags Grant 7,341,377 - Baxter March 11, 2 | 2008-03-11 |
| Method for creating specific, high affinity nuclear receptor pharmaceuticals Grant 7,302,347 - Baxter , et al. November 27, 2 | 2007-11-27 |
| Nuclear receptor ligands and ligand binding domains App 20070027215 - Baxter; John D. ; et al. | 2007-02-01 |
| Eye treatments using synthetic thyroid hormone compositions Grant 7,122,579 - Schwartz , et al. October 17, 2 | 2006-10-17 |
| Bovine growth hormone recombinantly produced in E. coli Grant 7,101,981 - Miller , et al. September 5, 2 | 2006-09-05 |
| Modulating nuclear receptor coactivator binding App 20060149521 - Baxter; John D. ; et al. | 2006-07-06 |
| Methods for modulating nuclear receptor coactivator binding Grant 6,965,850 - Baxter , et al. November 15, 2 | 2005-11-15 |
| Method for creating nuclear receptor activity modulating pharmaceuticals App 20040253648 - Fletterick, Robert J. ; et al. | 2004-12-16 |
| Method for creating specific, high affinity nuclear receptor pharmaceuticals App 20040110154 - Baxter, John D. ; et al. | 2004-06-10 |
| Bovine growth hormone Grant 6,692,941 - Miller , et al. February 17, 2 | 2004-02-17 |
| Eye treatments using synthetic thyroid hormone compositions App 20030175849 - Schwartz, Daniel M. ; et al. | 2003-09-18 |
| Eye treatments using synthetic thyroid hormone compositions Grant 6,555,582 - Schwartz , et al. April 29, 2 | 2003-04-29 |
| Methods And Compounds For Modulating Nuclear Receptor Coactivator Binding App 20020061539 - BAXTER, JOHN D. ; et al. | 2002-05-23 |
| Nuclear receptor ligands and ligand binding domains Grant 6,266,622 - Scanlan , et al. July 24, 2 | 2001-07-24 |
| Nuclear receptor ligands and ligand binding domains Grant 6,236,946 - Scanlan , et al. May 22, 2 | 2001-05-22 |
| Eye treatments using synthetic thyroid hormone compositions Grant 6,054,485 - Schwartz , et al. April 25, 2 | 2000-04-25 |
| Selective thyroid hormone analogs Grant 5,883,294 - Scanlan , et al. March 16, 1 | 1999-03-16 |
| Fusion peptides comprising an expressible bacterial gene and .beta.-endorphin Grant 4,469,631 - Baxter , et al. September 4, 1 | 1984-09-04 |
| Microbiological synthesis of beta endorphin Grant 4,350,764 - Baxter , et al. September 21, 1 | 1982-09-21 |
| Adrenocorticotropin-lipotropin precursor gene Grant 4,322,499 - Baxter , et al. March 30, 1 | 1982-03-30 |
| SEC | 0001226956 | BAXTER JOHN D |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 